Popular weight loss drugs such as Wegovy and Zepbound have shown incredible success in clinical trials. But in the real world ...

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its 2025-26 budget plans.

Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those ...

Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

So is it enough for a doctor to tell a chronically obese person to lose weight and leave it at that? Wyatt and Bray both point out that we routinely use medication for other conditions that can be ...

Despite the jump in the number of teens being prescribed Wegovy, it still represents only a small fraction of kids who are living with obesity. Approximately one in 5 children and teens in the U.S.

Weight-loss injections are the new quick fix. But a silent risk is catching women off guard – with life-changing consequences ...

Denmark-based multinational pharmaceutical company Novo Nordisk will make Wegovy, its approved weight-loss treatment for ...

4. WeightWatchers acquired Sequence for ~£100 million (March 2024) – Sequence, a telehealth platform providing access to GLP-1 weight-loss medications, was purchased to integrate prescription ...